vialroom

#semaglutide 2025-12-09

Tuesday23 messages6 participantstimes are UTC
Highlights from this day
  • lisbon_lot — is the plateau at 13 weeks normal or am i doing something wrong SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial 13:23
  • tokyo_taper — does the licensed ceiling for weight differ from the diabetes one 14:05
  • VialBot — Testing queue: 4 submissions open, 56 awaiting dispatch. 15:14
LL

half life is about a week so youre roughly four to five weeks to steady state on any new dose

📈2🧪1
LL

lost about 12kg on the low doses before i even got to 1, which surprised me

HL

steady state is the bit people skip, judging a new dose after eight days tells you almost nothing

LL

was SURPASS-2 the one that ran to 68 weeks or am i mixing them up

LL

is the plateau at 13 weeks normal or am i doing something wrong
SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial

vial-a-2418-front.png
900 × 1200 · 769 KB · not retained in the public archive

going slow cost me nothing except time and saved me two bad weeks, thats my whole contribution, not advice obviously

TT

the appetite effect faded for me around 13 months and going up fixed it for a while

is there a reason to hold at 1.7 rather than going to 2.4

FI

SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial

steady state takes weeks

slightly off topic but does anyone actually run a five week step instead of four

*week 28 not week 7

VB

Testing queue: 4 submissions open, 56 awaiting dispatch.

🎉62

*PeptideMeter not the other one

LN

i was wrong about the ceiling for a year, i thought 3 existed. it doesnt for the weight indication

anyone gone from 1 straight to 2 or is that too big a jump

how did people handle the jump from 1 to 1.7